Allspring Global Investments
AMED

Allspring Global Investments’s Amedisys AMED Stock Holding History

Allspring Global Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-152
Closed -$14.7K – 1780
2024
Q3 		$14.7K Sell
152
-4
-3% -$390 ﹤0.01% 2048
2024
Q2 		$14.3K Buy
156
+34
+28% +$3.15K ﹤0.01% 2170
2024
Q1 		$11.2K Buy
122
+23
+23% +$2.15K ﹤0.01% 2163
2023
Q4 		$9.41K Sell
99
-9
-8% -$841 ﹤0.01% 2025
2023
Q3 		$10.1K Sell
108
-39
-27% -$3.6K ﹤0.01% 2608
2023
Q2 		$13.4K Sell
147
-6
-4% -$492 ﹤0.01% 2516
2023
Q1 		$11.3K Sell
153
-42
-22% -$3.63K ﹤0.01% 2583
2022
Q4 		$16.3K Sell
195
-349,315
-100% -$31.5M ﹤0.01% 2631
2022
Q3 		$33.8M Sell
349,510
-84,157
-19% -$10M 0.06% 416
2022
Q2 		$45.6M Sell
433,667
-7,465
-2% -$954K 0.08% 334
2022
Q1 		$76M Sell
441,132
-85,725
-16% -$12.8M 0.1% 276
2021
Q4 		$85.3M Buy
+526,857
New +$84.7M 0.09% 288

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Allspring Global Investments's AMED Position: Q4 2024 in Review

Allspring Global Investments sold out of Amedisys (AMED) in Q4 2024, closing a stake of 152 shares — an estimated $14.7K sold.

Allspring Global Investments first reported a position in AMED in Q4 2021 and held it in 12 quarters. The position peaked at $85.3M in Q4 2021. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Allspring Global Investments reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 152 Amedisys shares in Q4 2024, an estimated $14.7K.
  • Allspring Global Investments first reported a position in Amedisys in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Amedisys position peaked at $85.3M in Q4 2021.
  • 290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.